Ellen Leich
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 30
- Oncology 28
- Viral-associated cancers and disorders 14
- Co-authors
- Andreas Rosenwald (37 shared papers)German Ott (14 shared papers)Heike Horn (6 shared papers)Martin Faßnacht (5 shared papers)Silviu Sbiera (5 shared papers)Cristina Lucia Ronchi (5 shared papers)Bruno Allolio (5 shared papers)Ralf Christian Bargou (13 shared papers)
- Journals
- Blood (9 papers)Leukemia (6 papers)Haematologica (6 papers)Blood Cancer Journal (4 papers)Nature Communications (3 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Ellen Leich
65 papers receiving 3.1k citations
Ellen Leich's Hit Papers
Peers
Comparison fields: 5 of 91
- Pathology and Forensic Medicine 1.5k
- Genetics 683
- Oncology 1.2k
- Cancer Research 549
- Hematology 286
Countries citing papers authored by Ellen Leich
This map shows the geographic impact of Ellen Leich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Leich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Leich more than expected).
Fields of papers citing papers by Ellen Leich
This network shows the impact of papers produced by Ellen Leich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Leich. The network helps show where Ellen Leich may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen Leich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry Hit paper breakdown → | 2015 | 514 |
| 2 | 2009 | 165 | |
| 3 | 2015 | 161 | |
| 4 | 2011 | 127 | |
| 5 | 2019 | 113 | |
| 6 | 2008 | 112 | |
| 7 | 2022 | 106 | |
| 8 | 2018 | 103 | |
| 9 | 2016 | 99 | |
| 10 | 2011 | 98 | |
| 11 | 2010 | 91 | |
| 12 | 2015 | 87 | |
| 13 | 2007 | 86 | |
| 14 | 2013 | 76 | |
| 15 | 2011 | 73 | |
| 16 | 2007 | 67 | |
| 17 | 2014 | 57 | |
| 18 | 2013 | 53 | |
| 19 | 2013 | 52 | |
| 20 | 2013 | 47 |
About Ellen Leich
Ellen Leich is a scholar working on Pathology and Forensic Medicine, Oncology, Hematology, Genetics and Cancer Research, having authored 67 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (30 papers), Multiple Myeloma Research and Treatments (15 papers), Viral-associated cancers and disorders (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Ubiquitin and proteasome pathways (8 papers), RNA Research and Splicing (7 papers), Protein Degradation and Inhibitors (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.5k citations), Genetics (683 citations), Oncology (1.2k citations), Cancer Research (549 citations) and Hematology (286 citations). Ellen Leich has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Andreas Rosenwald, German Ott, Heike Horn, Martin Faßnacht, Silviu Sbiera, Cristina Lucia Ronchi, Bruno Allolio, Ralf Christian Bargou, Tiemo Katzenberger and Jörg Kalla. Their work appears in journals such as Blood, Leukemia, Haematologica, Blood Cancer Journal and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.